AIM
PDLI

Ada Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Ada Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$64K Buy
+17,945
New +$75.1K 0.04% 378

Other funds holding PDLI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ada Investment Management's PDLI Position: Q4 2015 in Review

Ada Investment Management opened a new position in PDL BioPharma, Inc. (PDLI) in Q4 2015: 17,945 shares worth $64K. The stake represents 0.04% of the portfolio and ranks #378 among its holdings.

204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

  • Ada Investment Management held 17,945 shares of PDL BioPharma, Inc. worth $64K as of Q4 2015.
  • PDL BioPharma, Inc. was a new Ada Investment Management position in Q4 2015.
  • PDL BioPharma, Inc. made up 0.04% of Ada Investment Management's portfolio in Q4 2015, its #378 holding.
  • 204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.